DXCM
Dexcom, Inc.
Every pitch and position made on this ticker, across every competition and newsletter issue in the archive.
- Times pitched
- 3
- Long / short
- 0 / 3
- Avg. return
- —
- Verdicts
- Inconclusive 3
pitch
Winter 2016
Nielsen
short
inconclusive
Newsletter
Dexcom is facing significant challenges due to increasing competition from integrated devices that combine continuous glucose monitoring (CGM) technology with insulin pump therapy. The company's reven
pitch
Winter 2016
Marc Grow, CFA, Benjamin Ostrow, Evan Zehnal
short
inconclusive
Newsletter
Dexcom is overvalued due to market misconceptions about the competitive dynamics in the continuous glucose monitoring (CGM) industry and the actual patient benefits of its products. The company faces
pitch
Winter 2016
Marc Grow ’17, Benjamin Ostrow ’17, and Evan Zehnal ’17
short
inconclusive
Newsletter
Dexcom Inc. is facing significant challenges in its market position and competitive landscape, which could lead to a decline in its stock price. The company's growth may not sustain at the current lev